SpeeDx
- Business Wire
SpeeDx Receives Clearance for COVID-19 Diagnostic Test
Robust, dual-target test now available for sale in Australia SYDNEY–(BUSINESS WIRE)–#COVID19–SpeeDx Pty. Ltd. announced today their PlexPCR® SARS-CoV-2* test received…
Read More » - Technology
SpeeDx and MolGen Announce Partnership for COVID-19 Test Solution
Sydney, Australia & Utrecht, Netherlands: SpeeDx Pty, Ltd. and MolGen announced the signing of an agreement to collaborate on supply…
Read More » - Business
SpeeDx Receives CE-IVD Mark for PlexPCR® SARS-CoV-2
Sydney, Australia: SpeeDx Pty. Ltd. announced today it has received CE-IVD marking for its PlexPCR® SARS-CoV-2* assay – a two…
Read More » - Business
SpeeDx Increase Distribution Network
Sydney, Australia: SpeeDx have announced signing a new distribution partner, further extending customer access to market-leading SpeeDx ResistancePlus® and PlexPCR®…
Read More » - Health
SpeeDx Partners with Nepean Hospital to Commercialise Respiratory Virus Host Biomarker Assay
SpeeDx newly patented InSignia technology simplifies the measurement of gene expression and will underpin the creation of a simple, standardized…
Read More » - World
SpeeDx and Nepean Hospital Awarded Federal Funding for Viral Respiratory Biomarker Test
Utilising newly patented InSignia(TM) technology that enhances the measurement of gene expression, the test will be a rapid, high-throughput tool…
Read More »